Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Summary of Product Characteristics last updated on the eMC: 28/07/2011
SPC Logynon

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   18-Jul-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



The key changes to the SmPC are:

Section 4.6 (Pregnancy & Lactation) has been updated to bring it into line with the CCDS text.

Updated on 13/05/2011 and displayed until 28/07/2011
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   08-Apr-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

The key change is:

Section 2: ‘Qualitative and Quantitative Composition’ of the SmPC has been updated to reflect current standard terminology in line with the European Guideline on the Summary of Product Characteristics. There is a consequential change to section 4.4 with the addition of a 'Lactose and Sucrose Intolerance' warning; in line with the guidance in Notice to Applicants: ENTR/F2/BL D (2003).

Updated on 26/06/2009 and displayed until 13/05/2011
Reasons for adding or updating:
  • Change to section 6. 6 - Instructions for use, handling and disposal
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   06-Mar-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



The key changes to the SmPC are:

  • Section 6.6 (Special precautions for disposal) 'No special requirements' has been added.
  • Section 9 (Date of first authorisation / Renewal of the Authorisation) has been updated to the Renewal date - 6th March 2009.
  • Section 10 (Date of revision of the text) has been updated to the Renewal date - 6th March 2009.
Updated on 27/06/2008 and displayed until 26/06/2009
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-May-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



All updates are due to change of ownership, from Schering Healthcare Ltd to Bayer Plc effective from 1 May 2008.

Section 7: MAH now Bayer plc
Section 8: Licence number is now PL 00010/ 0540
Section 9: Date of first authorisation is now 1 May 2008
Section 10: Revision date is now 1 May 2008 

Updated on 15/05/2001 and displayed until 27/06/2008
Reasons for adding or updating:
  • No reasons supplied
Updated on 11/04/2001 and displayed until 15/05/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 12/09/2000 and displayed until 11/04/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 12/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   ethinylestradiol
   levonorgestrel